Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,168 | -21,397 | -88,602 | -61,503 | -41,904 |
| Depreciation Amortization | 1,206 | 615 | 2,455 | 1,784 | 1,152 |
| Accounts receivable | 1,160 | 455 | -1,138 | -2,070 | -704 |
| Accounts payable and accrued liabilities | -721 | 2,759 | -1,711 | -347 | 672 |
| Other Working Capital | -8,629 | 874 | 5,948 | 898 | 5,403 |
| Other Operating Activity | 6,934 | -2,307 | 10,461 | -2,170 | -4,462 |
| Operating Cash Flow | $-38,218 | $-19,001 | $-72,587 | $-63,408 | $-39,843 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -654 | -361 | -306 | -186 | -190 |
| Investing Cash Flow | $-654 | $-361 | $-306 | $-186 | $-190 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 25,000 | 25,000 | 110,000 | 110,000 | 110,000 |
| Common Stock Issued | 187 | N/A | 78,088 | 75,000 | 76,138 |
| Other Financing Activity | 0 | 187 | -110,172 | -108,345 | -110,159 |
| Financing Cash Flow | $25,187 | $25,187 | $77,916 | $76,655 | $75,979 |
| Exchange Rate Effect | -771 | -166 | 351 | 770 | 1,023 |
| Beginning Cash Position | 71,791 | 71,791 | 66,417 | 66,417 | 66,417 |
| End Cash Position | 57,335 | 77,450 | 71,791 | 80,248 | 103,386 |
| Net Cash Flow | $-14,456 | $5,659 | $5,374 | $13,831 | $36,969 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,218 | -19,001 | -72,587 | -63,408 | -39,843 |
| Capital Expenditure | -654 | -361 | -306 | -186 | -190 |
| Free Cash Flow | -38,872 | -19,362 | -72,893 | -63,594 | -40,033 |